Ascension Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $3.96M | Sell |
7,159
-290
| -4% | -$160K | 2.07% | 10 |
|
|
2024
Q1 | $4.33M | Buy |
+7,449
| New | +$4.33M | 2.33% | 8 |
|
|
2023
Q2 | $3.95M | Buy |
+7,574
| New | +$3.95M | 2.41% | 7 |
|
|
2022
Q4 | $4.2M | Sell |
7,624
-70
| -0.9% | -$38.5K | 3.03% | 4 |
|
|
2022
Q3 | $3.9M | Hold |
7,694
| – | – | 3.06% | 4 |
|
|
2022
Q2 | $4.18M | Buy |
+7,694
| New | +$4.18M | 3.08% | 4 |
|
|
2021
Q4 | $6.76M | Sell |
10,138
-30
| -0.3% | -$20K | 4.02% | 3 |
|
|
2021
Q3 | $5.81M | Sell |
10,168
-50
| -0.5% | -$28.6K | 3.8% | 4 |
|
|
2021
Q2 | $5.16M | Sell |
10,218
-125
| -1% | -$63.1K | 3.38% | 4 |
|
|
2021
Q1 | $4.72M | Buy |
+10,343
| New | +$4.72M | 3.31% | 4 |
|
|
2020
Q4 | – | Sell |
-10,763
| Closed | -$4.75M | – | 93 |
|
|
2020
Q3 | $4.75M | Buy |
+10,763
| New | +$4.75M | 3.8% | 4 |
|
|
2020
Q1 | $3.09M | Sell |
10,888
-75
| -0.7% | -$21.3K | 3.21% | 4 |
|
|
2019
Q4 | $3.56M | Sell |
10,963
-25
| -0.2% | -$8.12K | 3.07% | 4 |
|
|
2019
Q3 | $3.2M | Sell |
10,988
-1,100
| -9% | -$320K | 2.96% | 4 |
|
|
2019
Q2 | $3.55M | Hold |
12,088
| – | – | 3.13% | 3 |
|
|
2019
Q1 | $3.31M | Sell |
12,088
-50
| -0.4% | -$13.7K | 2.97% | 4 |
|
|
2018
Q4 | $2.72M | Sell |
12,138
-200
| -2% | -$44.8K | 2.76% | 4 |
|
|
2018
Q3 | $3.01M | Sell |
12,338
-217
| -2% | -$53K | 2.65% | 7 |
|
|
2018
Q2 | $2.6M | Sell |
12,555
-2,430
| -16% | -$503K | 2.38% | 8 |
|
|
2018
Q1 | $3.09M | Hold |
14,985
| – | – | 2.82% | 4 |
|
|
2017
Q4 | $2.85M | Buy |
+14,985
| New | +$2.85M | 2.59% | 5 |
|